Published in Sci Rep on August 10, 2016
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (1995) 8.68
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18
The MDM2 gene amplification database. Nucleic Acids Res (1998) 4.64
Human papillomavirus immortalization and transformation functions. Virus Res (2002) 3.58
Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39
The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol (2010) 3.08
Retinoblastoma. Lancet (2012) 2.98
The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol (2009) 2.04
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A (1998) 2.00
MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy. Curr Cancer Drug Targets (2005) 1.83
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol (2006) 1.75
MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem (2009) 1.63
Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene (2012) 1.58
MDM2 SNP309 variation increases cervical cancer risk among Asians. Tumour Biol (2014) 1.45
Retinoblastoma. Orphanet J Rare Dis (2006) 1.44
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians. Cancer Cell (2011) 1.40
The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress. Mol Cell Biol (2000) 1.30
The regulation of the p53-mediated stress response by MDM2 and MDM4. Cold Spring Harb Perspect Biol (2010) 1.23
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev (2007) 1.17
MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis (2006) 1.11
MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 1.10
Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res (2010) 1.09
MDM2 as a modifier gene in retinoblastoma. J Natl Cancer Inst (2010) 1.09
A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin Cancer Res (2008) 1.03
Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma. Tumour Biol (2015) 0.99
More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma. Front Genet (2012) 0.99
Frontiers in the management of retinoblastoma. Am J Ophthalmol (2009) 0.97
MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. Int J Cancer (2012) 0.93
Retinoblastoma. Curr Opin Ophthalmol (2013) 0.92
TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.88
No association between SNP309 promoter polymorphism in the MDM2 and cervical cancer in a study from northeastern Brazil. Cancer Detect Prev (2007) 0.86
Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma. Biomed Rep (2014) 0.84
Polymorphisms of CDKN1A gene and risk of retinoblastoma. Carcinogenesis (2013) 0.82
Association of p53 rs1042522, MDM2 rs2279744, and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population. Sci Rep (2015) 0.81
Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis. Mol Diagn Ther (2015) 0.80
Structural and sequential context of p53: A review of experimental and theoretical evidence. Prog Biophys Mol Biol (2014) 0.80
p53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma. J Hum Genet (2011) 0.80
Association between MDM2 rs769412 and rs937283 polymorphisms with alcohol drinking and laryngeal carcinoma risk. Int J Clin Exp Pathol (2015) 0.79
MDM2 (RS769412) G>A Polymorphism in Cigarette Smokers: a Clue for the Susceptibility to Smoking and Lung Cancer Risk. Asian Pac J Cancer Prev (2015) 0.76